financetom
Business
financetom
/
Business
/
California Weed Company Sells Santa Ana Dispensary Eliminating $44.5M In Debt
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
California Weed Company Sells Santa Ana Dispensary Eliminating $44.5M In Debt
Jun 18, 2024 6:36 AM

Blüm Holdings, Inc. (OTCQB:BLMH) announced Tuesday that its subsidiary Unrivaled Brands, Inc. has sold its controlling membership interest in People's First Choice LLC (PFC) to Haven Nectar LLC. PFC owns and operates a cannabis retail dispensary campus in Santa Ana, California named Blüm Santa Ana.

"The sale of our Santa Ana store is a landmark achievement for Blüm Holdings, not only because of the financial gain but because it symbolizes the end of a challenging era," stated Sabas Carrillo, CEO of Blüm Holdings. "Our team has fought tirelessly, often under immense pressure with little resources, to steer the company through litigation and restructuring. We are immensely proud of the team which includes AGMs, Inventory Managers, Drivers, and Guides at PFC who have made the Blüm Santa Ana store a remarkable asset. We believe the Blüm Santa Ana team now has a shot at the title of California’s best, and the rest of our teams are poised to compete and thrive in a revitalized company."

The Disposition Summary

The disposition marks an important step in the company's strategic restructuring plan, which began in August 2022. The key highlights include

$24.8 million total consideration: The consideration includes $9.00 million in cash and $15.84 million in assumption of liabilities.

Debt extinguishment: All of the cash generated in the disposition was used to settle debt and litigation. The transaction has extinguished an estimated $44.46 million in liabilities, reducing Blüm Holdings’ total debt by over 55%.

Significant financial gain: The total estimated gain from the disposition is $33.98 million, equivalent to $3.09 per common share.

Estimated $90 million in total liability reduction: This transaction is part of Blüm Holdings’ broader restructuring strategy, which has resulted in the reduction of total liabilities by an estimated $90 million since August 2022.

Pursuant to a trademark license agreement, Blüm Santa Ana will continue to use the Blüm name in connection with PFC's business for up to 18 months.

Price Action

Blüm Holdings shares closed Monday market session 10.29% lower at $0.4000 per share.

Related Links:

Blüm Holdings Q1 Revenue Drop 16% YoY, Eliminates Non-Performing Legacy Operations, Reduces Net Loss

Cannabis rescheduling seems to be right around the corner. Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Microsoft Delivers Another Strong Quarter with Impressive Results, Wedbush Says
Microsoft Delivers Another Strong Quarter with Impressive Results, Wedbush Says
Apr 26, 2024
12:30 PM EDT, 04/26/2024 (MT Newswires) -- Microsoft ( MSFT ) latest Q3 results showcased yet another strong quarter with impressive outcomes across the board, Wedbush said in a report Friday. Microsoft Azure's growth soared at 31%, surpassing both the Wall Street's estimate of 29% and the company's own guidance of 28%, driven by strong demand for their updated tech...
Johnson & Johnson Says Europe's CHMP Recommends Approval of Rybrevant Plus Chemotherapy for Lung Cancer Treatment
Johnson & Johnson Says Europe's CHMP Recommends Approval of Rybrevant Plus Chemotherapy for Lung Cancer Treatment
Apr 26, 2024
12:29 PM EDT, 04/26/2024 (MT Newswires) -- Johnson & Johnson's ( JNJ ) Janssen-Cilag International said Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use, or CHMP, has recommended the approval of Rybrevant (amivantamab), in combination with chemotherapy for the treatment of adult patients with advanced non-small cell lung cancer. The recommendation is supported by the...
Royal Caribbean, Seminole Gaming, Hard Rock Combining Rewards Programs in New Partnership
Royal Caribbean, Seminole Gaming, Hard Rock Combining Rewards Programs in New Partnership
Apr 26, 2024
12:27 PM EDT, 04/26/2024 (MT Newswires) -- Royal Caribbean Group (RCL) on Friday announced a new partnership allowing travelers on the cruise line's ships to book discounted rooms, meals and other benefits at Hard Rock International and Seminole Gaming locations by combining the three companies' respective rewards programs. The reciprocal agreement extends to Hard Rock and Seminole Gaming guests using...
Chemed Reports 'Soft' Q1 as Roto-Rooter Continues to Face Pressure, Oppenheimer Says
Chemed Reports 'Soft' Q1 as Roto-Rooter Continues to Face Pressure, Oppenheimer Says
Apr 26, 2024
12:35 PM EDT, 04/26/2024 (MT Newswires) -- Chemed's ( CHE ) Q1 results were a rare earnings miss as its Roto-Rooter unit continued to face pressure in the quarter coupled with ineffective returns on paid advertising, Oppenheimer said in a note Thursday. Chemed ( CHE ), however, continues to offer an attractive and stable investment opportunity, the research firm said....
Copyright 2023-2026 - www.financetom.com All Rights Reserved